Minerva Neurosciences (NERV) Stock: Buy, Sell, or Hold?
$2.30
-0.08 (-3.36%)
âŧ
5d:
-4.96%
30d:
-4.96%
90d:
-47.96%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (56%)
Quality Score
40/100
Position
SLIGHTLY LOW
30-Day Fair Range
$2.19 â $2.91
Position: SLIGHTLY LOW
Forward P/E & Valuation
-5.5x
Next 12M consensus est.
Wall Street Target
$10.33
+349.3% upside
Options IV & Volume
46th pct IV
HIGH volume confirmation
Support / Resistance
$2.20 / $2.76
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: NERV is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When NERV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NERV is currently trading at $2.30, which is considered slightly low relative to its 30-day fair value range of $2.19 to $2.91.
Technical Outlook: Technically, NERV is in a strong downtrend. Immediate support is located at $2.20, while resistance sits at $2.76. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: NERV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.33 (+349.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NERV is in a strong downtrend. Immediate support is located at $2.20, while resistance sits at $2.76. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: NERV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.33 (+349.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.19 -
$2.91
Company Quality Score
40/100
(HOLD)
Options IV Signal
46th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
Trading Range & Key Levels
30-Day Trading Range
$2.19 -
$2.91
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
Âą$0.55
(23.7%)
Support Level
$2.20
Resistance Level
$2.76
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 46th percentile)
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 349.3% below Wall St target ($10.33)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.48
Wall Street Target
$10.33
(+349.3%)
Share NERV Analysis
Share this live NERV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NERV)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $NERV with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NERV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 31 SELL |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
14 analysts |
$34 | 55 HOLD |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NERV Research Pages
